| Literature DB >> 27618076 |
Lifang Hou1, Kai Zhang2, Moira A Luthin3, Andrea A Baccarelli4.
Abstract
The U.S. Environmental Protection Agency (EPA) recently issued a notice of violation against Volkswagen (VW) for installing a defective device in certain models of diesel cars to circumvent emission tests for nitrogen oxides (NOx). We quantified the health and economic impacts of extra NOx emissions attributable to non-compliant vehicles in the U.S. using the EPA's Co-Benefits Risk Assessment model. We estimated that the total extra NOx emitted over one year of operation would result in 5 to 50 premature deaths, 687 to 17,526 work days with restricted activity, and economic costs of $43,479,189 to $423,268,502, based on various assumptions regarding emission scenarios and risks. This study highlights the potential impacts of VW vehicles' lack of compliance on the health and well-being of the U.S.Entities:
Keywords: nitrogen oxides; risk assessment; vehicle emissions
Mesh:
Substances:
Year: 2016 PMID: 27618076 PMCID: PMC5036724 DOI: 10.3390/ijerph13090891
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Total emissions and estimated annual premature deaths, hospital admissions, and diseases attributable to Volkswagen vehicles’ lack of compliance with EPA standards in the U.S.
| Emissions and Health Outcomes | Best-Case Scenario | Midpoint | Worst-Case Scenario |
|---|---|---|---|
| Emissions | |||
| Assumed NOx emissions against EPA’s current Tier 2 vehicle emission standard (0.07 grams per mile) a | 10× | 25× | 40× |
| Metric tons of extra NOx released annually by non-compliant vehicles | 3414 | 9105 | 14,796 |
| Mortality | |||
| Premature deaths in adults, lower-risk assumption b | 5 | 13 | 22 |
| Premature deaths in adults, higher-risk assumption b | 12 | 31 | 50 |
| Diseases and symptoms | |||
| Asthma exacerbations | 154 | 407 | 660 |
| Acute bronchitis | 8 | 21 | 34 |
| All respiratory symptoms | 247 | 654 | 1061 |
| Hospital admissions | |||
| Hospital admissions related to respiratory and cardiovascular diseases | 3 | 9 | 14 |
| Asthma emergency room visits | 3 | 8 | 13 |
| Impact on work productivity | |||
| Days of work lost | 687 | 1816 | 2946 |
| Days with minor restrictions in activity | 4085 | 10,805 | 17,526 |
a Best-case, midpoint, and worst-case scenarios assume NOx emissions released from VW affected cars were respectively 10, 25, or 40 times higher on average than the EPA standard of 0.07 grams per mile; b The EPA Co-Benefits Risk Assessment (COBRA) model generates low and high boundaries of estimates for premature deaths and heart attacks in adults based on high and low reports of risk from different reference studies.
Estimated annual economic costs (2010 US dollars) of premature deaths, hospital admissions, and diseases attributable to Volkswagen vehicles’ lack of compliance with EPA standards in the United States a.
| Health Outcomes | Best-Case Scenario | Midpoint | Worst-Case Scenario |
|---|---|---|---|
| Mortality | |||
| Premature deaths in adults, lower risk assumption b | $42,777,243 | $113,441,872 | $184,106,754 |
| Premature deaths in adults, higher risk assumption b | $97,013,943 | $257,278,035 | $417,543,579 |
| Diseases and symptoms | |||
| Asthma exacerbations | $8,804 | $23,302 | $37,800 |
| Acute bronchitis | $3,804 | $10,066 | $16,329 |
| All respiratory symptoms | $6,918 | $18,307 | $1,061 |
| Hospital admissions | |||
| Hospital admissions related to respiratory and cardiovascular diseases | $110,216 | $292,655 | $475,095 |
| Asthma emergency room visits | $1,273 | $3,382 | $5,491 |
| Impact on work productivity | |||
| Days of work lost | $109,665 | $290,091 | $470,517 |
| Days with minor restrictions in activity | $276,577 | $731,636 | $1,186,696 |
| Total economic losses, lower-risk assumptions b | $43,479,189 | $115,301,466 | $187,124,000 |
| Total economic losses, higher-risk assumptions b | $98,344,726 | $260,805,876 | $423,268,502 |
a A 3% discount rate was used in estimating economic value; b The EPA COBRA model generates low and high boundaries of estimates for premature deaths in adults and other outcomes based on high and low reports of risk from different reference studies (lower and higher risk assumptions use the concentration–response functions from two studies: Krewski et al. (2009) [13] and Lepeule et al. (2012) [14], respectively). This table shows selected endpoints from the COBRA model’s results. Thus, the estimates of total economic losses are larger than the sum of economic costs for each endpoint shown in this table.